ACUTA CAPITAL PARTNERS, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001582844

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 28 positions · Total reported value $96.77M · Top-10 concentration 76.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 52.9% · 11 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 28 equity positions with a combined reported value of $96.77M. The filing implies a focused portfolio: its ten largest positions account for 76.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were OCUL ($13.62M), CDTX ($13.55M), TRML ($12.84M). By sector, the heaviest allocations are Health Care 68.8%, Other 31.2%. Versus the prior quarter, allocation shifted toward Health Care (+1.5pp) and away from Other (-1.5pp).

Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions. The portfolio's overlap with the prior quarter was 56% of names.

The largest new positions opened in Q3 2025 were AMLX ($4.53M), CMPX ($2.94M), KRYS ($1.87M).

Of the 8 positions fully exited versus the prior quarter, the largest were SLNO ($5.31M), TRVI ($2.70M), HLXB ($1.99M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • AMLX AMYLYX PHARMACEUTICALS INC · $4.53M
  • CMPX COMPASS THERAPEUTICS INC · $2.94M
  • KRYS KRYSTAL BIOTECH INC · $1.87M
  • COGT COGENT BIOSCIENCES INC · $1.48M
  • DNTH DIANTHUS THERAPEUTICS INC · $983.75K
  • UTHR UNITED THERAPEUTICS CORP DEL · $962.51K
  • INBX INHIBRX BIOSCIENCES INC · $551.58K
  • LBRX LB PHARMACEUTICALS INC · $473.70K

Fully Exited (vs previous quarter)

  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $5.31M
  • TRVI TREVI THERAPEUTICS INC · prev qtr: $2.70M
  • HLXB HELIX ACQUISITION CORP II · prev qtr: $1.99M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $1.06M
  • LQDA LIQUIDIA CORPORATION · prev qtr: $945.41K
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $865.88K
  • RAPP RAPPORT THERAPEUTICS INC · prev qtr: $227.40K
  • ARTV LATIGO BIOTHERAPEUTICS INC · prev qtr: $68.64K · history

Insider Transactions (Form 4)

Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-136966 (status: Approved), registered 2026-09-09
  • Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: acutacapital.com

Portfolio Structure

  • 23 positions · $143.49M reported value (Q2 2026)
  • Top 10 holdings = 73.7% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
  • Average position size: $6.24M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 68.8%
Other 31.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.17M $13.62M 14.08%
14.08%
Add
2 141.53K $13.55M 14.01%
14.01%
Reduce
3 268.45K $12.84M 13.27%
13.27%
Reduce
4 3.41M $6.48M 6.70%
6.70%
Hold
5 38.59K $5.56M 5.74%
5.74%
Add
6 84.88K $5.15M 5.32%
5.32%
Add
7 6.38K $4.70M 4.86%
4.86%
Reduce
8 333.26K $4.53M 4.68%
4.68%
New
9 502.80K $3.78M 3.90%
3.90%
Add
10 25.11K $3.31M 3.42%
3.42%
Reduce
11 840.09K $2.94M 3.04%
3.04%
New
12 49.75K $2.64M 2.73%
2.73%
Reduce
13 178.41K $2.30M 2.38%
2.38%
Add
14 9.79K $1.95M 2.01%
2.01%
Reduce
15 10.57K $1.87M 1.93%
1.93%
New
16 101.78K $1.79M 1.85%
1.85%
Reduce
17 454.83K $1.49M 1.54%
1.54%
Reduce
18 102.91K $1.48M 1.53%
1.53%
New
19 80.14K $1.37M 1.42%
1.42%
Reduce
20 143.45K $1.27M 1.31%
1.31%
Reduce
21 25.00K $983.75K 1.02%
1.02%
New
22 2.30K $962.51K 0.99%
0.99%
New
23 16.38K $551.58K 0.57%
0.57%
New
24 57.14K $525.70K 0.54%
0.54%
Reduce
25 30.00K $473.70K 0.49%
0.49%
New
26 8.41K $392.79K 0.41%
0.41%
Reduce
27 59.98K $261.54K 0.27%
0.27%
Reduce
28 90.83K $18.36K 0.02%
0.02%
Hold

FAQ

What did ACUTA CAPITAL PARTNERS, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 28 equity positions worth $96.77M in aggregate; its largest disclosed positions were OCUL ($13.62M), CDTX ($13.55M), TRML ($12.84M).

How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?

ACUTA CAPITAL PARTNERS, LLC reported $96.77M of long equity holdings across 28 positions as of 2025-Q3. Top-10 holdings account for 76.0% of reported value.

What is ACUTA CAPITAL PARTNERS, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/acuta-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →